TradingKey – Johnson & Johnson Earnings Release Approaching: Solid Revenue Expectation Fails to Conceal Profit Pressure, but Wall Street Remains Broadly Bullish on Stock

On October 12 Eastern Time, healthcare giant Johnson & Johnson (JNJ) saw its stock price come under pressure ahead of its earnings release, dipping 0.26% in pre-market trading to $260.77. Tomorrow (October 13) before the U.S. market opens, Johnson & Johnson will officially report its Q3 FY2026 financial results. Will this drive its stock price higher?

As a bellwether for healthcare and defensive blue-chip stocks, Johnson & Johnson is widely expected by the market to report solid revenue growth overall in its upcoming earnings report, though profit faces slight pressure…